Regulation (EC) No 726/2004 Article 60

Article 60

At the request of the Commission, the Agency shall, in respect of authorised medicinal products, collect any available information on methods that Member States' competent authorities use to determine the added therapeutic value that any new medicinal product provides.

Read the full instrument → · Read this in context: TITLE IV — THE EUROPEAN MEDICINES AGENCY - RESPONSIBILITIES AND ADMINISTRATIVE STRUCTURE →

Other provisions in TITLE IV — THE EUROPEAN MEDICINES AGENCY - RESPONSIBILITIES AND ADMINISTRATIVE STRUCTURE

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationArticle 60 of Regulation (EC) No 726/2004 (LawPlayer, data as of 2026-07-04)

What to look at next

Regulation (EC) No 726/2004, full textChapter navigation and full text, so you can read this section in contextEuropean Union legislation EU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and year TITLE IV — THE EUROPEAN MEDICINES AGENCY - RESPONSIBILITIES AND ADMINISTRATIVE STRUCTURE — read this in contextThe surrounding text of the act in order, so you can see what comes before and afterChapters and sections